Key result
Automated 12SL software detects STEMI with ~91% sensitivity, potentially cutting door-to-device time by 17 minutes.
Why the study?
Many patients with STEMI who walk into the emergency department experience delays and worse outcomes due to delayed diagnosis and treatment.
Does automated software ECG interpretation reduce door-to-device times in patients presenting to the emergency department with STEMI?
Observational (n=379)
Yes
Does automated software ECG interpretation reduce door-to-device times in patients presenting to the emergency department with STEMI?
Automated software ECG interpretation for STEMI is highly specific and sensitive, and could significantly reduce door-to-device times for walk-in ED patients.
May shorten D2D times for walk-in STEMI; leaves open whether software ECG transmission improves outcomes in routine care.
BACKGROUND: Prehospital diagnosis of ST-elevation myocardial infarction (STEMI) has resulted in improved outcomes. However, many patients still walk in to the emergency department (ED) with STEMI, experiencing delays and worse outcomes. Software electrocardiogram (ECG) diagnosis of STEMI and electronic transmission to a cardiologist may result in improved door-to-device (D2D) times. METHODS: We retrospectively identified all patients presenting with STEMI from January 2015 to September 2016. Components of delay in D2D, ED variables, and the patients' ECGs were extracted from our regional database. All ECGs performed for suspected myocardial infarction in the region were extracted over the study period. We assessed the accuracy of the software 12SL in diagnosing STEMI, ED contributors to delays in D2D, and the potential reduction in D2D if software diagnosis of STEMI resulted in activation of the cardiac catheterization laboratory. RESULTS: A total of 379 patients presented to an ED in our region and received primary percutaneous coronary intervention over the study period. In the 143,574 ECGs performed over the study period for suspected STEMI, the overall sensitivity and specificity of 12SL were 90.5% and 99.98%, respectively. We estimated a potential 17-minute reduction in D2D in the 90.5% of patients correctly identified as having STEMI, with a false activation rate of 4%. Female patients and older patients experienced an even larger potential benefit, with 24- and 25-minute reductions in D2D, respectively. CONCLUSIONS: Patients who walk in to an ED with STEMI experience significant system-related delays in recognition and treatment. Automated software diagnosis of STEMI is accurate and could result in significant improvements in D2D times.
No takes yet. Share an insight, caveat, or question.
Cloutier et al. (2020) conducted an observational in ST-elevation myocardial infarction (STEMI) (n=379). Software 12SL electrocardiographic interpretation was evaluated on Accuracy of software 12SL in diagnosing STEMI and potential reduction in door-to-device time. Automated software diagnosis of STEMI using 12SL demonstrated 90.5% sensitivity and 99.98% specificity, with an estimated potential 17-minute reduction in door-to-device time.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: